Cargando…

Using the affective bias test to predict drug‐induced negative affect: implications for drug safety

BACKGROUND AND PURPOSE: Predicting the risk of drug‐induced adverse psychiatric effects is important but currently not possible in non‐human species. We investigated whether the affective bias test (ABT) could provide a preclinical method with translational and predictive validity. EXPERIMENTAL APPR...

Descripción completa

Detalles Bibliográficos
Autores principales: Stuart, S A, Wood, C M, Robinson, E S J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595760/
https://www.ncbi.nlm.nih.gov/pubmed/28782244
http://dx.doi.org/10.1111/bph.13972
_version_ 1783263412392820736
author Stuart, S A
Wood, C M
Robinson, E S J
author_facet Stuart, S A
Wood, C M
Robinson, E S J
author_sort Stuart, S A
collection PubMed
description BACKGROUND AND PURPOSE: Predicting the risk of drug‐induced adverse psychiatric effects is important but currently not possible in non‐human species. We investigated whether the affective bias test (ABT) could provide a preclinical method with translational and predictive validity. EXPERIMENTAL APPROACH: The ABT is a bowl‐digging task, which quantifies biases associated with learning and memory. Rats encounter independent learning experiences, on separate days, under either acute manipulations (e.g. pro‐depressant vs. control) or different absolute reward values (e.g. high vs. low). A bias is observed during a preference test when an animal's choices reflect their prior experience. We investigated the effects of putative pro‐depressant drug treatments following acute or chronic administration on the formation of an affective bias or reward‐induced positive bias respectively. KEY RESULTS: The immunomodulators LPS (10 μg·kg(−1)), corticosterone (10 and 30 mg·kg(−1)) and IFN‐α (100 U·kg(−1)) induced a negative affective bias following acute treatment. Tetrabenazine (1 mg·kg(−1)) also induced a negative bias, but no effects were observed with varenicline, carbamazepine or montelukast. Chronic treatment with IFN‐α (100 U·kg(−1)) and retinoic acid (10 mg·kg(−1)) impaired the formation of a reward‐induced positive bias but did not alter sucrose preference test (SPT). CONCLUSIONS AND IMPLICATIONS: The ABT has the potential to provide a novel approach to predict pro‐depressant risk in a non‐human species. Negative biases induced by acute treatment in the standard version of the task may also predict longer‐term effects on reward processing as shown by the deficit in reward‐induced positive bias following chronic treatment, an effect distinct from anhedonia in the SPT. LINKED ARTICLES: This article is part of a themed section on Pharmacology of Cognition: a Panacea for Neuropsychiatric Disease? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.19/issuetoc
format Online
Article
Text
id pubmed-5595760
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-55957602017-09-15 Using the affective bias test to predict drug‐induced negative affect: implications for drug safety Stuart, S A Wood, C M Robinson, E S J Br J Pharmacol Themed Section: Research Paper BACKGROUND AND PURPOSE: Predicting the risk of drug‐induced adverse psychiatric effects is important but currently not possible in non‐human species. We investigated whether the affective bias test (ABT) could provide a preclinical method with translational and predictive validity. EXPERIMENTAL APPROACH: The ABT is a bowl‐digging task, which quantifies biases associated with learning and memory. Rats encounter independent learning experiences, on separate days, under either acute manipulations (e.g. pro‐depressant vs. control) or different absolute reward values (e.g. high vs. low). A bias is observed during a preference test when an animal's choices reflect their prior experience. We investigated the effects of putative pro‐depressant drug treatments following acute or chronic administration on the formation of an affective bias or reward‐induced positive bias respectively. KEY RESULTS: The immunomodulators LPS (10 μg·kg(−1)), corticosterone (10 and 30 mg·kg(−1)) and IFN‐α (100 U·kg(−1)) induced a negative affective bias following acute treatment. Tetrabenazine (1 mg·kg(−1)) also induced a negative bias, but no effects were observed with varenicline, carbamazepine or montelukast. Chronic treatment with IFN‐α (100 U·kg(−1)) and retinoic acid (10 mg·kg(−1)) impaired the formation of a reward‐induced positive bias but did not alter sucrose preference test (SPT). CONCLUSIONS AND IMPLICATIONS: The ABT has the potential to provide a novel approach to predict pro‐depressant risk in a non‐human species. Negative biases induced by acute treatment in the standard version of the task may also predict longer‐term effects on reward processing as shown by the deficit in reward‐induced positive bias following chronic treatment, an effect distinct from anhedonia in the SPT. LINKED ARTICLES: This article is part of a themed section on Pharmacology of Cognition: a Panacea for Neuropsychiatric Disease? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.19/issuetoc John Wiley and Sons Inc. 2017-08-30 2017-10 /pmc/articles/PMC5595760/ /pubmed/28782244 http://dx.doi.org/10.1111/bph.13972 Text en © 2017 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Themed Section: Research Paper
Stuart, S A
Wood, C M
Robinson, E S J
Using the affective bias test to predict drug‐induced negative affect: implications for drug safety
title Using the affective bias test to predict drug‐induced negative affect: implications for drug safety
title_full Using the affective bias test to predict drug‐induced negative affect: implications for drug safety
title_fullStr Using the affective bias test to predict drug‐induced negative affect: implications for drug safety
title_full_unstemmed Using the affective bias test to predict drug‐induced negative affect: implications for drug safety
title_short Using the affective bias test to predict drug‐induced negative affect: implications for drug safety
title_sort using the affective bias test to predict drug‐induced negative affect: implications for drug safety
topic Themed Section: Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595760/
https://www.ncbi.nlm.nih.gov/pubmed/28782244
http://dx.doi.org/10.1111/bph.13972
work_keys_str_mv AT stuartsa usingtheaffectivebiastesttopredictdruginducednegativeaffectimplicationsfordrugsafety
AT woodcm usingtheaffectivebiastesttopredictdruginducednegativeaffectimplicationsfordrugsafety
AT robinsonesj usingtheaffectivebiastesttopredictdruginducednegativeaffectimplicationsfordrugsafety